Conference Program Book Northern California Chapter Society of Nuclear Medicine and Molecular Imaging Annual Meeting

Transcription

1 2015 Northern California Chapter Society of Nuclear Medicine and Molecular Imaging Annual Meeting Conference Program Book February 26, 2015 Doubletree by Hilton Pleasanton at the Club Pleasanton, CA

2 Accreditation Evaluation/Credit Reporting Forms Attendees will receive Evaluation and Credit Reporting Forms as part of their registration material. ACCME (AMA-PRA): This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Society of Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) and the Central Chapter SNMMI. The SNMMI is accredited by the ACCME to provide continuing medical education for physicians. The Society of Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. VOICE: The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this meeting for a maximum of (number of hours: 6.0) continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A credit. Participants will receive CE credit for those sessions at which they were present a minimum of 80%. VOICE+ (Category A+) credits will be approved for a limited number of sessions. Please note the NMTCB and ARRT will recognize Category A+ credits. Exhibit Area Attendees are encouraged to visit the Exhibit Hall during the following times: Thursday, February 26th 7:00 am - 1:30 pm It is the attendee s responsibility to sign in before each session using your assigned keypad and having the Attendance Verification Form submitted upon completion of the program.

3 Course Schedule Thursday, February 26, :30 am Registration Foyer Continental Breakfast Exhibit Room 7:30 am Opening Remarks Andrew Quon, MD, Stanford University Medical Center, Stanford, CA President, NCSNMMI SNMMI Leadership Update Hossein Jadvar, MD, PhD, University of Southern California, Pasadena, CA President-Elect, SNMMI Session # 1 Erik Mittra, MD, PhD, Stanford Hospital and Clinics, Stanford, CA 7:45 8:30am Update on Radiopharmaceuticals for Myocardial Perfusion Imaging Ryan Niederkohr, MD (R), Kaiser Permanente Santa Clara Hospital, Santa Clara, CA 8:30 9:15am Update on Clinical Protocols for Myocardial Perfusion Imaging Dawn Holley, CNMT (I), Lucas Center for Imaging, Stanford University, Stanford, CA 9:15 10:15am PET and SPECT Imaging of the Brain Andrew Quon, MD (I), Stanford University Medical Center, Stanford, CA 10:15 10:45 am Break in Exhibits Session # 2 Andrew Quon, MD, Stanford University Medical Center, Stanford, CA 10:45 11:45am Radionuclide Based Theragnostics for Neuroendocrine Tumors Erik Mittra, MD, PhD (T), Stanford Hospital and Clinics, Stanford, CA 11:45am 12:30pm Positron Emission Tomography of Prostate Cancer Hossein Jadvar, MD, PhD (I), University of Southern California, Pasadena, CA 12:30-1:30 pm Buffet Lunch/Dessert in the Exhibit Area Session # 3 Cameron Foster, MD, UC Davis Medical Center, Davis, CA 1:30 2:15pm Back to Basics: Renal Imaging Cameron Foster, MD (I), UC Davis Medical Center, Davis, CA 2:15 3:15pm Systemic Targeted Therapy in Prostate Cancer Miguel Pampaloni, MD, PhD (T), University of California-San Francisco, San Francisco, CA

4 Faculty List Cameron Foster, MD UC Davis Medical Center Davis, CA Dawn Holley, BS, CNMT, RT(N)(CT) PET/MR Research Technologist Lucas Center for Imaging Stanford University Stanford, CA Hossein Jadvar, MD, PhD, MPH, MBA, FACNM University of Southern California Pasadena, CA Erik Mittra, MD, PhD Stanford Hospital and Clinics Stanford, CA Ryan Niederkohr, MD Kaiser Permanente Santa Clara Hospital Santa Clara, CA Miguel Hernandez Pampaloni, MD, PhD University of California, San Francisco Department of Radiology & Biomedical Imaging San Francisco, CA David K. Shelton, MD UC Davis Medical Center Vacaville, CA Andrew Quon, MD Stanford University Medical Center Stanford, CA

5 Exhibitor Listing Astellas Pharma US, Inc. One Astellas Way Northbrook, IL P: 608/ E: Astellas Pharma US, Inc., a subsidiary of Tokyobased Astellas Pharma, Inc., is a research-based pharmaceutical company dedicated to improving the health of people around the world through innovative pharmaceutical products. Astellas ranks among the top 20 pharmaceutical companies in the world. For more information on Astellas, please go to Bayer HealthCare Pharmaceuticals 100 Bayer Blvd Whippany, NJ P: 862/ E: karen.mcdonald@bayer.com Bracco Diagnostics, Inc. PO Box 339 Dayton, NV P: 775/ E: linda.piper@diag.bracco.com At the forefront of cardiac PET for 24 years and counting... Bracco Diagnostics Inc. was the first company to invest heavily in cardiac PET MPI. Since 1989, CardioGen-82 (Rubidium Rb 82 Generator) has been the only FDA-approved generator-based perfusion agent available for cardiac PET. We remain passionate about the future of cardiac PET and the patients we serve. Additionally, Bracco is the manufacturer of Choletec and Kinevac. Cardinal Health 1007 Canal Blvd Richmond, CA P: 925/ E: cindy.kragen@cardinalhealth.com The NPS mission is to advance the diagnosis and treatment of disease through the use of radiopharmaceuticals and new biotracers. For over a quarter of a century, the Nuclear Pharmacy Services business of Cardinal Health has set the standard for the radiopharmaceutical industry. Nuclear Pharmacy Services, whose network of over 150 pharmacies fills 65% of radiopharmaceutical unit doses nationwide, has consistently demonstrated leadership through innovation and a commitment to excellence. Because of this commitment, our customers and their patients benefit from the safest, most efficient methods of dispensing radiopharmaceuticals. Cardinal Health leverages the resources of our nationwide network to make certain our customers receive the support they need in regulatory compliance, reimbursement, practice development, continuing education, information management and other crucial areas. This enables our customers to be more cost effective so they can focus on their patients. IBA Molecular Atlantic Blvd, Ste. 730 Dulles, VA 20166, P: 703/ ; F: 571/ IBA Molecular is a global developer, manufacturer and distributor of radiopharmaceutical products and supporting services used in molecular imaging. We have engineered a strong and unique product portfolio of diagnostic and therapeutic tracers. We also provide educational content, technical, research and marketing support to medical specialists worldwide to help better respond to patient needs. For more information, please visit PETNET Solutions 810 Innovation Drive Knoxville, TN P: 877/ ; F: 847/ Siemens is a pioneer in the development of new imaging techniques and applications for clinical imaging. The combination of PET to visualize the biological processes of life and the anatomical imaging capabilities of CT, offer the finest resolution1 in the industry of 87mm3 based on 400x400 matrix recon PET CT imaging, providing diagnostic confidence. Accurate1 xspect2 alignment and total integration of SPECT and CT deliver the ability tonot only image disease, but to leverage high resolution to identify and follow disease over time with quantitative capabilities to adjust treatment earlier. 1. Based on competitive literature available at time of publication. Data on file. 2. Biograph mct Flow, Biograph mct Flow 3. Edge, Symbia Intevo and xspect are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

6 PETNET Solutions Inc., a wholly owned subsidiary of Siemens Medical Solutions USA, Inc., operates the world's largest network of PET radiopharmacies, with over 50 locations worldwide. With the largest global network of integrated manufacturing operations and PET nuclear pharmacies, as well as partnerships with key pharmaceutical and industry partners, Siemens PETNET Solutions is uniquely able to offer access to PET tracers needed today, as well as those to expand clinical offerings in the future. Thinking Systems Corporation th Avenue N., Ste. 205 St. Petersburg, FL P: 727/ ; F: 727/ E: xing@thinkingsystems.com Thinking Systems, the recognized industry leader of cloud-based enterprise PACS/RIS,will exhibits its revolutionary cloud-based PACS ThinkingWeb Extreme. ThinkingWeb Extreme utilizes the most advanced cloud technology and 64-bit server platform to provide the most comprehensive PACS functionalities for all modalities. It enables physicians to perform diagnostic interpretation/reporting from anywhere through Internet for general radiology and complex specialty modalities, including CT/MR/CR,PET-CT, SPECT- CT, nuclear cardiology, general nuclear medicine, cardiac PET, PET brain, echo, cardiac cath, etc. Triad Isotopes 4205 Vineland Road, Suite L1 Orlando, FL P: 407/ ; F: 407/ E: mjohnson@triadisotopes.com Triad Isotopes is proud of our reputation for outstanding service, which has helped us become the second-largest and fastest-growing radiopharmaceutical specialist in the country. We are proud of the relationships we have with thousands of physicians and nuclear medicine providers nationwide that consider us partners in delivering their patients the custom solutions they rely on for diagnosis and treatment. Discover more at

7 Disclosure Statements All speakers have been asked to disclose any significant relationships they may have with commercial companies that may have a direct or indirect relationship to the subject matter of the presentation. These relationships have been disclosed as seen below: Cameron Foster, MD Dawn Holley, BS, CNMT, RT(N)(CT) Hossein Jadvar, MD, PhD, MPH, MBA, FACNM Erik Mittra, MD, PhD Ryan Niederkohr, MD Miguel Hernandez Pampaloni, MD, PhD David K. Shelton, MD Andrew Quon, MD

8 Learning Objectives Thursday, February 26, :30 am Registration Foyer Continental Breakfast Exhibit Room 7:30 am Opening Remarks Andrew Quon, MD, Stanford University Medical Center, Stanford, CA SNMMI Leadership Update Hossein Jadvar, MD, PhD, University of Southern California, Pasadena, CA President-Elect, SNMMI Session # 1 Erik Mittra, MD, PhD, Stanford Hospital and Clinics, Stanford, CA 7:45 8:30am Update on Radiopharmaceuticals for Myocardial Perfusion Imaging Ryan Niederkohr, MD (R), Kaiser Permanente Santa Clara Hospital, Santa Clara, CA 1. Examine available and upcoming radiopharmaceuticals used for myocardial perfusion imaging. 2. Explain potential advantages and disadvantages of PET-based tracers with SPECT-based tracers. 3. Compare radiation exposure associated with use of various myocardial perfusion tracers. 8:30 9:15am Update on Clinical Protocols for Myocardial Perfusion Imaging Dawn Holley, CNMT (I), Lucas Center for Imaging, Stanford University, Stanford, CA 1. Compare and contrast various clinical protocols for myocardial perfusion imaging. 2. Highlight differences between PET and SPECT myocardial perfusion imaging protocols. 3. Evaluate PET/MR cardiac imaging. 9:15 10:15am PET and SPECT Imaging of the Brain Andrew Quon, MD (I), Stanford University Medical Center, Stanford, CA 1. Examine the physiological basis of the tracers used in Nuclear Medicine brain imaging. 2. Examine the basis of interpretation of Nuclear Medicine exams of the brain. 3. Review the clinical indications for various Nuclear Medicine brain imaging exams. 10:15 10:45 am Break in Exhibits

9 Session # 2 Andrew Quon, MD, Stanford University Medical Center, Stanford, CA 10:45 11:45am Radionuclide Based Theragnostics for Neuroendocrine Tumors Erik Mittra, MD, PhD (T), Stanford Hospital and Clinics, Stanford, CA 1) Examine the biology of neuroendocrine tumors, with a focus on radionuclide targets 2) Review SPECT and PET imaging of neuroendocrine tumors. 3) Examine how therapy is related to biology and imaging, and review current updates on the status of PRRT in the US. 11:45am 12:30pm Positron Emission Tomography of Prostate Cancer Hossein Jadvar, MD, PhD (I), University of Southern California, Pasadena, CA 1) Review the major biological targets that may be useful for imaging in prostate cancer. 2) Recognize the need for tailoring the imaging technique to the particular clinical phase of disease. 3) Analyze the current evidence with the potential utility of PET with various radiotracers in the imaging evaluation of prostate cancer. 12:30-1:30 pm Buffet Lunch/Dessert in the Exhibit Area Session # 3 Cameron Foster, MD, UC Davis Medical Center, Davis, CA 1:30 2:15pm Back to Basics: Renal Imaging Cameron Foster, MD (I), UC Davis Medical Center, Davis, CA 1) Examine the common radiotracers and indications for nuclear medicine renal imaging. 2) Identify the normal, abnormal and common artifact findings on renal imaging cases. 3) Review technical considerations when dealing with pediatric renal cases. 2:15 3:15pm Systemic Targeted Therapy in Prostate Cancer Miguel Pampaloni, MD, PhD (T), University of California-San Francisco, San Francisco, CA 1) Describe with the current techniques for systemic targeted therapy in prostate cancer. 2) Examine the biophysics and radiation hazards related to these therapies. 3) Examine the pathophysiology of prostate cancer metastasis and sensitivity to radiation.

10 Notes Page

11 Notes Page Save The Date 2015 Western Region SNM Annual Meeting October 22-25, 2015 Hyatt Regency Monterey Monterey, CA